Are you familiar with our IRIS Clinical Trial? It's an important step in our work with Autism Spectrum Disorder (ASD). At MapLight Therapeutics, we are committed to advancing research and developing innovative treatments for ASD. Learn more about the IRIS Trial and our dedication to making a difference with potential new treatments for this community. https://lnkd.in/e9YaUN6H
MapLight Therapeutics, Inc.
Biotechnology Research
Palo Alto, CA 8,049 followers
Creating breakthrough innovative therapeutics for serious CNS disorders
About us
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
- Website
-
http://maplightrx.com
External link for MapLight Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Palo Alto, CA
- Type
- Privately Held
Locations
-
Primary
Palo Alto, CA, US
-
Boston, Massachusetts, US
Employees at MapLight Therapeutics, Inc.
-
Susmita Chatterjee PhD
Senior Director @ MapLight Therapeutics | Neuroscience
-
Tim Garnett
Pharmaceutical Executive, Board Member and retired Chief Medical Officer
-
Charmaine Lykins
Chief Commercial Officer (CCO) at Maplight Therapeutics
-
Lauren Colfer
Development Operations Executive | Large Pharma & Start Up Biotech| Experience leading multiple therapeutic areas in various stages of drug…
Updates
-
This month is off to a strong start with the National Plan to End Parkinson’s Act signed into law on July 2, 2024. With this law now in effect, the U.S. Department of Health and Human Services (HHS) will establish the National Parkinson’s Project, a first-ever federal initiative to prevent and cure Parkinson’s disease, treat its symptoms and slow or stop its progression. Further, HHS will establish a federal advisory council that will provide recommendations and guidance for progressing against Parkinson’s disease and atypical parkinsonisms. This is a huge win for the Parkinson’s community. Learn more via our partners at The Michael J. Fox Foundation for Parkinson's Research. https://lnkd.in/ePmyyBHh #ParkinsonsDisease #Parkinsons #NationalPlantoEndParkinsons #NewLaw
-
Which of our therapeutic research areas do you have a personal connection to? Participate in our poll and let us know. Your feedback helps us understand and engage with our community better. Thank you for your input and engagement! If you want to share a story that explains your personal connection, please feel free to do so in the comments. ⬇️ Participation is voluntary and not required to participate in the poll.
This content isn’t available here
Access this content and more in the LinkedIn app
-
Happy 4th of July from all of us at MapLight Therapeutics, Inc.! As we celebrate Independence Day, we honor the courage and dedication of all those working towards a brighter future for our country and people with CNS conditions. Wishing everyone a safe and joyful holiday! 🇺🇸
-
July is National Minority Mental Health Awareness Month. According to the Centers for Disease Control and Prevention, many people from racial and ethnic minority groups have difficulty accessing mental health care and therapy – these barriers include cost, inadequate health insurance, difficulty finding providers from one's racial or ethnic group, and stigma about mental health care, which prevent many from seeking necessary services. MapLight is committed to supporting equitable access to mental health services and potential new treatments. Learn more about our work in the mental health space as it relates to schizophrenia: https://lnkd.in/gWgc-BdZ
-
As we come close to the end of Alzheimer's and Brain Awareness Month, remember that there is currently no FDA approved medication for the treatment of Alzheimer’s disease psychosis. At MapLight, we're dedicated to advancing research in this critical area. Learn more about our work. https://lnkd.in/d5wESj-M
-
Curious about working at MapLight? Tiffany Streett, our Senior Manager of Quality Systems, shares her experience: "It's exciting to wake up in the morning knowing I'm part of a visionary company, working to find solutions to often-overlooked patient populations." Discover career opportunities at MapLight. https://lnkd.in/dgHz9Mrx
-
Our multi-prong approach to drug discovery - optogenetics, transcriptomics, and STARmap. Learn more about our discovery platform. https://lnkd.in/gudWcFta
-
Did you know that about 40% of people diagnosed with Alzheimer's disease will experience delusions and hallucinations – this is a condition known as Alzheimer’s disease psychosis. Learn more about our work to discover and develop potential new treatments for people with Alzheimer's disease psychosis.https://https://lnkd.in/d5wESj-M
-
Looking for a rewarding career? MapLight is hiring for several key roles, including Manager, Clinical Supply Chain, Clinical Research Associate, Senior Director, Biostatistics, and more. Apply today: https://lnkd.in/dgHz9Mrx